Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1-Reference-Cited by-同舟云学术

Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1

Published:2012-09-26 Issue:24 Volume:86 Page:13384-13396
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Aoki M.,Danish M. L.,Aoki-Ogata H.,Amano M.,Ide K.,Das D.,Koh Y.,Mitsuya H.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference41 articles.

1. A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro;Amano;Antimicrob. Agents Chemother.,2007

2. Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors;Aoki;J. Virol.,2009

3. In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors;Back;AIDS,2000

4. Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir;Baxter;J. Virol.,2006

5. Efficacy and safety of two doses of tipranavir/ritonavir versus lopinavir/ritonavir-based therapy in antiretroviral-naïve patients: results of BI 1182.33;Cooper,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants;Science Advances;2023-07-14

2. Viral proteases as therapeutic targets;Molecular Aspects of Medicine;2022-12

3. Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands;ChemMedChem;2022-03-04

4. Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance;Chemical Communications;2022

5. Precursors of Viral Proteases as Distinct Drug Targets;Viruses;2021-10-02